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INTRODUCTION
We had been studied about gastrointestinal en-
doscopy for a long time. However, sometimes, it is very
difficult to make a diagnosis for small cancerous lesions.
In order to make a diagnosis for small cancerous lesion,
we should keep special endoscopic technique. Although
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succinimide ester (ICG-sulfo-OSu) and 3-ICG-acyl-1, 3-thiazolidine-2-thione (ICG-ATT) as
an infrared fluorescent-labelingreagent. ICG-derivative-labeledmouseanti-humancarcinoembryonic
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the ability of a reinforcement agent, octylglucoside, to intensity fluorescence from the labeled
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lesions and labeled with ICG-derivative can be imaged with this IRFE.
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we made all efforts that we could, it was very difficult
for us to make a diagnosis of microcancer. Thus,
changing the way of thinking to that of an ordinary
person, we have established a new type of diagnostic
method that requires no particular expertise.
The progress ofmedical instruments is remarkable.
Recently, fiberscopes have increasingly been replaced
by videoendoscopes. Videoendoscope is characterized
by live pictures as seen on television. Because images
are processed as electronic signals in videoendoscope,
diagnosis of microcancer, which is usually undetectable
through endoscopy, can be made in examination
of a micro lesion that is invisible through mac-
roscopy if the lesion is labeled with an antibody to
be identified by videoendoscope and electronic signals
from the labeled substance are processed by a com-
puter to produce images. However, new diagnostic
system using special characteristic of videoendo-
scope has not been established.
To establish this method, the following steps
were required:1) the development of a biologically
applicable labeled substance, 2) the development
of a videoendoscope that is able to detect the
labeled substance, and 3) the establishment of a
vital immunohistochemical staining.
Fluorescence-labeled substances are good can-
didates for step #1. However,mostknown fluorescence-
labeled substances fluoresce in the presence of
ultraviolet (UV) irradiation.Moreover, there aremany
biological tissues that can spontaneously fluoresce
when irradiated with UV and visible light, causing
background noise.
We had a vague idea that it might become possible
to establish a new diagnostic system. At the time when
we thought such an idea, the Gulf War broke out. At
the US-Iraq talks, James Baker, the former Secretary
of the U.S.A., took a tough stance against Iraqi
explanation that no Iraqi troops invaded Kuwait. It
is said that the U.S.A. had continuously watched
that Iraqi troops had been moving toward Kuwait.
The U.S.A. succeeded in detecting the movement of
some Iraqi soldiers based on computer-processed
infrared data, which were obtained live via satellite.
If several Iraqi soldiers can be identified by a satellite,
it should be possible to make a diagnosis at a cellular-
level through endoscopy. Thus, we began to investigate
infrared rays as we developed an interest in it.
CHARACTERISTIC OF INFRARED RAYS
Infrared rays show high permeability, with which
Iraqi soldiers were identified even under clouds. Such
a characteristic of infrared rays has been applied to
various technologies, such as endoscopy and non-
destructive analysis of agricultural products. Infrared
endoscope has been used for the observation of
submucosal lesions and in vivo analysis of various
substances. Unlike ultraviolet rays, infrared rays have
no effects on DNA; they are benign rays for the human
body. The most significant characteristic of infrared
rays is that they produce no background noise, which
is because of the absence of any substances emitting
infrared fluorescence in vivo.Thus, if a diagnostic system
using a substance labeled with infrared fluorescence
is developed, diagnosis of a micro lesion becomes
feasible. We therefore began to develop a diagnostic
system for a microcancer using infrared fluorescence
endoscopy.
INFRARED FLUORESCENCE SUBSTANCE
It was very difficult to find a substance labeled with
infrared fluorescence, which can be used in vivo .
However, we unexpectedly found such a substance
in the field of ophthalmology, where ICG has been
clinically utilized as an infrared fluorescence substance.
Unfortunately, ICG cannot be used as a labeled
substance because it has no protein-binding group.
Thus, we began to synthesize an ICG derivative that
has a protein-binding group. This is the beginning of
our research in this area.
Finally we succeeded in synthesizing an ICG
derivative (ICG-sulfo-Osu)with aproteinbindinggroup
(Figure 1)(1). This derivative is a substance labeled
with infrared fluorescence emitting 807 nm of fluo-
rescence at 768 nm of excitation light (Figure 2).
INFRAREDFLUORESCENT IMAGINGSYSTEM
Thus, we experimentally produced an infrared
fluorescent system using an excitation filter with
transmission at 710-790 nm and a barrier filter
with transmission at 810-920 nm (2, 3). We performed
various basic examinations using this imaging system.
IMMUNOHISTOCHEMICAL STAINING
We treated a paraffin section of a gastric cancer
tissue using an anti-CEA antibody labeled with the
ICG derivative to carry out infrared fluorescent
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observation. Although nothing was detectable under
visible rays because the section was only treated with
a labeled antibody, infrared fluorescence was seen on
the lesion through infrared fluorescent observation
(Figure 3)(4).
VITAL IMMUNOSTAINING
In vivo immunostaining is essential for this technique
to be utilized in endoscopic diagnosis; however, no
method has been established yet. Thus, we examined
in vivo immunostaining using nude mice. A human
gastric cancer was transplanted to the animals. The
tumor was exposed under etherization. A tissue sample
was collected after treated with an antibody. Im-
munostaining was performed using the ABCmethod.
Where anti-MUC1 mucin antibody had been applied
in vivo to the cleaved surface of the grafted gastric
cancer, the reaction product was demonstrated at the
luminary aspect of neoplastic glands. In positive controls,
strong reactivity was seen, but in the negative
control, reactivity was not observed (Figure 4)(5, 6).
INFRARED FLUORESCENT ENDOSCOPE
Thus, we experimentally began to develop an infrared
fluorescent endoscope with the same type of filters
Figure 1．The chemical structure of ICG (A) and ICG-sulfo-
OSu(B)
Figure 2．The excitation and emission spectrum of ICG (A)
and ICG-sulfo-OSu (B)
Figure 3．Infrared fluorescence imaging with ICG-sulfo-OSu
labed anti-CEA antibody.
A : Image with visible rays B : Image with infrared fluorescence
C : Composite image
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(Figure 5)(7). We performed an examination using
a resected fresh specimen treated with an anti-
CEA antibody labeled with an ICG derivative.
After treating a resected fresh specimen with an
anti-CEA antibody labeled with an ICG derivative,
infrared fluorescent endoscopic images of a gastric
cancerous lesion were taken. Infrared fluores-
cence was seen on the cancerous lesion (Figure 6)
(7). When a lesion was removed and dyed with
immunostaining according to the ABC method,
color development of diamino benzidine(DAB) was
observed on the site where infrared fluorescence
was seen.
NEW ICG DERIVATIVE
Furthermore, we synthesized ICG-ATT as an ICG
derivative with a stronger fluorescent intensity. The
basic structure of ICG-ATT remains the same but the
protein-binding group was different (Figure 7)(8).
ICG and two types of ICG derivatives showed almost
the same absorbance curve. As for fluorescence
curve, there was little difference in the basic wavelength
between ICG and two types of ICG derivatives al-
though the wave form of ICG-ATTwas slightly different
(Figure 8, 9)(8). Figure 10 shows infrared fluorescence
observed after treating a paraffin section with a
labeled antibody. ICG-ATT showed slightly stronger
fluorescence (9).
Figure 4．Vital immunostaining of human gastric cancers grafted into nude mouse.
A : Negative control B : Vital immunostaining
C : Conventional immunostaining
Figure 5．Infrared fluorescent endoscopy system
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REINFORCEMENT AGENTS
It was also found that some types of drugs (oc-
tylglucosid:OG) can be used as a reinforcement agent
(10). With increasing concentration, the peak fluo-
rescence wavelength lengthened;an increase in the
OG concentration from 10 to 100mM resulted in a
shift of peak fluorescence wavelength from800 to 817nm
(Figure 11)(10). Figure 12 shows infrared fluores-
cence images of sections treated with ICG-sulfo-
OSu-MUC1-Ab solutions with or without OG. Without
OG (Fig. 12 A), slight fluorescence was observed,
however with 100 mM OG (Fig. 12 B), marked fluo-
rescence was observed after image processing (10).
Figure 6．Infrared fluorescence imaging of freshly resected human gastric cancer tissue using ICG-sulfo-OSu labeled anti-CEA antibody.
A : Image with visible rays B : Image with infrared fluorescence
Figure 8．Absorption spectrum of ICG-ATT-(A) and ICG-sulfo
-OSu-labeled anti-MUC1 antibodies(B).
Figure 7．The chemical structures of ICG-ATT(A) and ICG-sulfo
-OSu(B)
Figure 9．Fluorescent spectrum of ICG-ATT-(A) and ICG-sulfo
-OSu-labeled anti-MUC1 antibodies (B).
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DISCUSSION
Although a diagnostic method of microcancer using
in vivo immunostaining has not been established yet,
an ICG derivative has been synthesized as a labeled
substance that can be used in vivo and a reinforcement
agent has successfully been developed. An infrared
fluorescent endoscope has also been developed
though experimentally. Although no immunostaining
has been performed in vivo, the results of examinations
using resected fresh specimens and nude mice indicate
that in vivo immunostainingmay be feasible.We believe
that further investigation of cancer-specific antibodies
will contribute to further progress inmolecular biology.
As stated above, although a lot of problems remain
Figure 10．Infrared fluorescence observed after treating a paraffin section with ICG-ATT-(A) and ICG-sulfo-OSu-(B) labeled
antibody.
Figure 11． The excitation and emission spectra of ICG-sulfo-Osu
labeled anti-MUC1 antibody before (a, b) and after(a’,b’) treated
with reinforcement agent (ocutylglucoside) for fluorescence.
: excitation spectra, : emission spectra Figure 12．Infrared fluorescence image of sections treated
with ICG-sulfo-OSu labeled anti MUC1 antibody with (B) or
without(A) ocutylglucoside.
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unsolved, we consider that they were at least partly
solved.
As for in vivo immunostaining, Keller et al, inGermany
successfully detected dysplasia in a model of ulcerative
colitis using an existing substance labeled with fluo-
rescence and a fluorescent endoscope(12). As for
infrared fluorescence, the result of a study using cathepsin
B-antibodies was reported (13). In the editorials in
the same issue of the journal, titled“the coming
revolution in gastrointestinal imaging,”it is written
that bioendoscopy utilizing in vital immunostaining
brought about a revolution in endoscopic diagnosis
(14). The results of our study on infrared fluorescence
were also mentioned in this editorial.
The progress of molecular biology is more re-
markable than that of medical instruments. Human
genome will soon be decoded and screening of various
diseases based on genetic information will become
available. We believe that the establishment of genetic
diagnosis as a screening tool will have consider-
able influence on the course of medicine in the 21st
century. Extremely high risk groupswhich have been
screened in genetic diagnosis will be targeted. Thus,
it will become essential to develop a system that can
detect a very small lesion that is undetectable based
on the currently available diagnostic systems or tools.
In the post-genome era, a screening system based
on genetic diagnosis will be established and a new type
of endoscopy targeting an extremely high risk population
will become clinically available. Various types of new
medical instruments will be developed and further
advancement will be expected. We believe that the
establishment of infrared fluorescent endoscopy will
be an example of such progress in medicine.
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